General
Cairo Pharmaceuticals (CPCI.CA) - The Central Authority of Accountancy Report
Published at 24 September 2026 at 07:11Cairo PharmaceuticalsRelated stock:Cairo Pharmaceuticals stockAll Cairo Pharmaceuticals disclosures
Disclosure summary
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The Central Authority of Accountancy Report for the financial for the year ended on 30/06/2026.
The Central Authority of Accountancy Report (801 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
The Central Authority of Accountancy Report for the financial for the year ended on 30/06/2026.
The Central Authority of Accountancy Report (801 KB)